Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(37)
Опубликована: Май 22, 2024
Though
platinum
(Pt)-based
complexes
have
been
recently
exploited
as
immunogenic
cell
death
(ICD)
inducers
for
activating
immunotherapy,
the
effective
activation
of
sufficient
immune
responses
with
minimal
side
effects
in
deep-seated
tumors
remains
a
formidable
challenge.
Herein,
we
propose
first
example
near-infrared
(NIR)
light-activated
and
lysosomal
targeted
Pt(II)
metallacycle
(1)
supramolecular
ICD
inducer.
1
synergistically
potentiates
immunomodulatory
response
via
multiple-regulated
approaches,
involving
NIR
light
excitation,
boosted
reactive
oxygen
species
(ROS)
generation,
good
selectivity
between
normal
tumor
cells,
enhanced
penetration/retention
capabilities.
Specifically,
has
excellent
depth-activated
ROS
production
(~7
mm),
accompanied
by
strong
anti-diffusion
anti-ROS
quenching
ability.
In
vitro
experiments
demonstrate
that
exhibits
significant
cellular
uptake
generation
cells
well
respective
multicellular
spheroids.
Based
on
these
advantages,
induces
more
efficient
an
ultralow
dose
(i.e.,
5
μM)
compared
clinical
inducer-oxaliplatin
(300
μM).
vivo,
vaccination
further
serves
potent
inducer
through
eliciting
CD8
Chemistry - A European Journal,
Год журнала:
2024,
Номер
30(10)
Опубликована: Янв. 3, 2024
Abstract
Platinum
complexes
are
potential
antitumor
drugs
in
chemotherapy.
Their
impact
on
tumor
treatment
could
be
greatly
strengthened
by
combining
with
immunotherapy.
Increasing
evidences
indicate
that
the
activity
of
platinum
is
not
limited
to
chemical
killing
effects,
but
also
extends
immunomodulatory
actions.
This
review
introduced
general
concept
chemoimmunotherapy
and
summarized
progress
as
chemoimmunotherapeutic
agents
recent
years.
developed
into
inducers
immunogenic
cell
death,
blockers
immune
checkpoint,
regulators
signaling
pathway,
modulators
microenvironment,
etc.
The
synergy
between
chemotherapeutic
effects
reinforces
complexes,
helps
them
circumvent
drug
resistance
systemic
toxicity.
exploration
for
may
create
new
opportunities
revive
discovery
metal
anticancer
drugs.
Angewandte Chemie International Edition,
Год журнала:
2022,
Номер
62(8)
Опубликована: Дек. 22, 2022
Zinc
homeostatic
medicine
is
of
great
potential
for
cancer
chemo-immunotherapy;
however,
there
are
few
reports
on
antitumor
compounds
that
can
trigger
Zn2+
-mediated
immune
responses.
In
this
work,
we
developed
a
novel
cyclometalated
PtIV
-terthiophene
complex,
Pt3,
not
only
induces
DNA
damage
and
cellular
metabolism
dysregulation,
but
also
disrupts
zinc
homeostasis
as
indicated
by
the
abnormal
transcriptional
level
regulatory
proteins,
excess
accumulation
in
cytoplasm,
down-regulation
metallothioneins
(MTs),
which
further
caused
redox
imbalance.
The
simultaneous
disruption
response
to
Pt3
treatment
activated
gasdermin-D
mediated
pyroptosis
accompanied
cytoskeleton
remodeling,
thus
releasing
pro-inflammatory
cytokines
promote
dendritic
cell
(DC)
maturation
T
tumor-infiltration,
eventually
eliminating
both
primary
distant
tumors
vivo.
As
far
know,
first
metal
complex
regulate
activate
immunity.
Advanced Healthcare Materials,
Год журнала:
2023,
Номер
12(19)
Опубликована: Март 11, 2023
Abstract
As
the
first
line
of
host
defense
against
pathogenic
infections,
innate
immunity
plays
a
key
role
in
antitumor
immunotherapy.
The
cyclic
GMP‐AMP
synthase
(cGAS)‐stimulator
interferon
genes
(STING)
(cGAS‐STING)
pathway
has
attracted
much
attention
because
secretion
various
proinflammatory
cytokines
and
chemokines.
Many
STING
agonists
have
been
identified
applied
into
preclinical
or
clinical
trials
for
cancer
However,
fast
excretion,
low
bioavailability,
nonspecificity,
adverse
effects
small
molecule
limit
their
therapeutic
efficacy
vivo
application.
Nanodelivery
systems
with
appropriate
size,
charge,
surface
modification
are
capable
addressing
these
dilemmas.
In
this
review,
mechanism
cGAS‐STING
is
discussed
agonists,
focusing
on
nanoparticle‐mediated
therapy
combined
cancers,
summarized.
Finally,
future
direction
challenges
nano‐STING
expounded,
emphasizing
pivotal
scientific
problems
technical
bottlenecks
hoping
to
provide
general
guidance
its
Angewandte Chemie International Edition,
Год журнала:
2023,
Номер
62(24)
Опубликована: Апрель 11, 2023
Abstract
cGAS‐STING‐mediated
DNA
sensing
is
demonstrated
to
be
critical
for
launching
antitumor
immunity.
However,
DNA‐based
cGAS‐STING
agonists
are
rarely
reported
owing
low
cell
permeability,
poor
biostability
and,
especially,
limited
length
of
exogenous
DNA.
Here,
we
present
a
virus‐like
particle
which
self‐assembled
from
long
building
blocks
generated
through
rolling‐circle
amplification
(RCA)
and
covered
with
cationic
liposomes.
Based
on
densely
packed
structure,
it
could
efficiently
induce
liquid
phase
condensation
cGAS
activate
STING
signaling
produce
inflammatory
cytokines.
Moreover,
this
also
trigger
the
formation
AIM2
inflammasome
gasdermin
D‐mediated
pyroptosis,
boosting
Thus,
study
provides
simple
robust
strategy
cancer
immunotherapy
clinical
application.
This
first
report
intrinsic
immunogenicity
RCA
products,
thus
facilitating
their
biomedical
applications.
National Science Review,
Год журнала:
2023,
Номер
11(1)
Опубликована: Дек. 18, 2023
ABSTRACT
Mounting
evidence
suggests
that
strategies
combining
DNA-damaging
agents
and
stimulator
of
interferon
genes
(STING)
agonists
are
promising
cancer
therapeutic
regimens
because
they
can
amplify
STING
activation
remodel
the
immunosuppressive
tumor
microenvironment.
However,
a
single
molecular
entity
comprising
both
has
not
yet
been
developed.
Herein,
we
designed
two
PtIV-MSA-2
conjugates
(I
II)
containing
chemotherapeutic
drug
cisplatin
innate
immune-activating
agonist
MSA-2;
these
showed
great
potential
as
multispecific
small-molecule
drugs
against
pancreatic
cancer.
Mechanistic
studies
revealed
conjugate
I
upregulated
expression
transcripts
associated
with
immunity
metabolism
in
cells,
significantly
differing
from
MSA-2.
An
analysis
microenvironment
demonstrated
could
enhance
infiltration
natural
killer
(NK)
cells
into
tumors
promote
T
NK
dendritic
tissues.
These
findings
indicated
I,
which
was
created
by
incorporating
Pt
one
molecule,
is
potent
anticancer
candidate,
opening
new
avenues
for
small-molecule-based
metalloimmunotherapy.
European Journal of Immunology,
Год журнала:
2023,
Номер
53(9)
Опубликована: Июль 9, 2023
Cyclic
GMP-AMP
synthase
(cGAS)
monitors
dsDNA
in
the
cytosol
response
to
pathogenic
invasion
or
tissue
injury,
initiating
cGAS-STING
signaling
cascades
that
regulate
various
cellular
physiologies,
including
IFN
/cytokine
production,
autophagy,
protein
synthesis,
metabolism,
senescence,
and
distinct
types
of
cell
death.
is
crucial
for
host
defense
homeostasis;
however,
its
dysfunction
frequently
leads
infectious,
autoimmune,
inflammatory,
degenerative,
cancerous
diseases.
Our
knowledge
regarding
relationships
between
death
rapidly
evolving,
highlighting
their
essential
roles
pathogenesis
disease
progression.
Nevertheless,
direct
control
by
signaling,
rather
than
IFN/NF-κB-mediated
transcriptional
regulation,
remains
relatively
unexplored.
This
review
examines
mechanistic
interplays
apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
autophagic/lysosomal
We
will
also
discuss
pathological
implications
human
diseases,
particularly
autoimmunity,
cancer,
organ
injury
scenarios.
hope
this
summary
stimulate
discussion
further
exploration
complex
life-or-death
responses
damage
mediated
signaling.
Angewandte Chemie International Edition,
Год журнала:
2023,
Номер
62(36)
Опубликована: Июль 19, 2023
G-quadruplexes
(G4s)
have
been
revived
as
promising
therapeutic
targets
with
the
development
of
immunotherapy,
but
G4-mediated
immune
response
remains
unclear.
We
designed
a
novel
class
G4-binding
organic-platinum
hybrids,
L1
-cispt
and
-transpt,
spatial
matching
for
G4
binding
DNA
reactivity
site
locking.
The
solution
structure
-transpt-MYT1L
demonstrated
effectiveness
covalent
revealed
binding-guided
dynamic
balance,
accompanied
by
destruction
A5-T17
base
pairs
to
achieve
platinum
unit
N7
G6
residue.
Furthermore,
-cispt-
-transpt-mediated
genomic
dysfunction
could
activate
retinoic
acid-induced
gene
I
(RIG-I)
pathway
induce
immunogenic
cell
death
(ICD).
use
-cispt/L1
-transpt-treated
dying
cells
vaccines
stimulated
robust
effectively
inhibited
tumor
growth
in
vivo.
Our
findings
highlight
importance
rational
combination
specific
recognition
locking
G4-trageting
drug
design
their
potential
immunotherapy.
Abstract
Cancer
immunotherapy
has
become
a
mainstream
cancer
treatment
over
traditional
therapeutic
modes.
cells
can
undergo
programmed
cell
death
including
ferroptosis,
pyroptosis,
autophagy,
necroptosis,
apoptosis
and
cuproptosis
which
are
find
to
have
intrinsic
relationships
with
host
antitumor
immune
response.
However,
direct
use
of
inducers
or
regulators
may
bring
about
severe
side
effects
that
also
be
rapidly
excreted
degraded
low
efficacy.
Nanomaterials
able
carry
them
for
long
circulation
time,
high
tumor
accumulation
controlled
release
achieve
satisfactory
effect.
Nowadays,
large
number
studies
focused
on
nanomedicines‐based
strategies
through
modulating
modalities
potentiate
immunity.
Herein,
types
their
function
first
summarized,
state‐of‐the‐art
research
progresses
in
nanomedicines
mediated
pathways
(e.g.,
cuproptosis)
response
provocation
highlighted.
Subsequently,
the
conclusion
outlook
potential
focus
discussed.
Journal of Medicinal Chemistry,
Год журнала:
2023,
Номер
66(18), С. 13072 - 13085
Опубликована: Сен. 13, 2023
To
develop
next-generation
metal
drugs
with
high
efficiency
and
low
toxicity
for
targeting
inhibition
of
gastric
tumor
growth
metastasis,
we
not
only
optimized
a
series
ruthenium
(Ru,
III)
2-hydroxy-1-naphthaldehyde
thiosemicarbazone
complexes
to
obtain
Ru(III)
complex
(4b)
remarkable
cytotoxicity
in
vitro
but
also
constructed
4b-decitabine
(DCT)/liposome
(Lip)
delivery
system
(4b-DCT-Lip).
The
vivo
results
showed
that
4b-DCT-Lip
had
stronger
capacity
inhibit
metastasis
than
4b-DCT
addressed
the
co-delivery
problems
improved
their
ability.
Furthermore,
confirmed
mechanism
4b-DCT/4b-DCT-Lip
inhibiting
tumor.
DCT-upregulated
gasdermin
E
(GSDME)
was
cleaved
by
4b-activated
caspase-3
afford
GSDME-N
terminal
then
aggregated
form
nonselective
pores
on
cell
membrane
tumor,
thereby
inducing
pyroptosis
pyroptosis-induced
immune
response.
Acta Pharmaceutica Sinica B,
Год журнала:
2023,
Номер
14(4), С. 1742 - 1758
Опубликована: Дек. 16, 2023
Mitochondrial
membrane
remodeling
can
trigger
the
release
of
mitochondrial
DNA
(mtDNA),
leading
to
activation
cellular
oxidative
stress
and
immune
responses.
While
role
in
promoting
inflammation
hepatocytes
is
well-established,
its
effects
on
tumors
have
remained
unclear.
In
this
study,
we
designed
a
novel
Pt(IV)
complex,
OAP2,
which
composed
oxaliplatin
(Oxa)
acetaminophen
(APAP),
enhance
anti-tumor
amplify
response.
Our
findings
demonstrate
that
OAP2
induces
nuclear
damage,
resulting
production
DNA.
Additionally,
downregulates
expression
Sam50,
promote
mtDNA
secretion,
double-stranded
accumulation
ultimately
synergistically
activating
intracellular
cGAS-STING
pathway.
The
induced
by
overcomes
limitations
Oxa
STING
pathway
simultaneously
promotes
gasdermin-D-mediated
cell
pyroptosis.
also
dendritic
maturation
enhances
quantity
efficacy
cytotoxic
T
cells,
thereby
inhibiting
cancer
proliferation
metastasis.
Briefly,
our
study
introduces
first
small-molecule
inhibitor
regulates
for
active
immunotherapy
research,
may
provide
creative
idea
targeting
organelle
therapy.